On Monday, President Trump signed an executive order limiting federal funds from being used for studies involving what is called “gain-of-function” research, which is a contentious area of science.
This study, often referred to as “dual-use” research, focuses on experiments with viruses and other disease-causing organisms that could potentially cause widespread outbreaks. Such investigations may reveal ways in which these microorganisms can increase their ability to spread from person to person or worsen the illness they produce.
This area has consistently been contentious due to worries that researchers might create a more hazardous pathogen in their laboratory which could escape and trigger a pandemic. These apprehensions have resulted in
numerous attempts throughout the years to enhance surveillance and regulation of this research
.
However, gain-of-function research turned particularly contentious and politically divisive during the COVID-19 pandemic. A hypothesis regarding the origin of the outbreak suggests that the SARS-CoV-2 virus, responsible for causing COVID-19, may have escaped from a Chinese governmental lab located in Wuhan, China.
“Many people believe that gain-of-function research was one of the key causes of the COVID pandemic that struck us in the last decade,” said White House secretary Will Scharf. “What this executive order does first of all, it provides powerful new tools to enforce the ban on federal funding for gain-of-function research abroad. It also strengthens other oversight mechanisms related to that issue and creates an overarching strategy to ensure that biomedical research in general is being conducted safely.”
Numerous researchers disagree with that theory, contending that the accumulated evidence indicates the outbreak began when an individual in China contracted the virus from a wild animal.
This being true, numerous researchers concur that enhanced supervision is essential due to potential hazards. However, many fear that an embargo might be overly extensive and could hinder secure studies which are crucial for preventing or tackling future pandemics.
“If we prohibit it now, when another COVID virus emerges in the future, we will lack the necessary data to swiftly develop new treatments, screenings, and preventive strategies,” he states.
Kristin Matthews
a scholar focusing on science and technology policy at Rice University’s Baker Institute for Public Policy.
However, some prefer limiting the funding.
“If one of these pathogens is released accidentally or if they are released deliberately, they can cause pandemics,” said
Richard Ebright
, a microbiologist at Rutgers University who subscribes to the so-called “lab-leak” theory to explain how the pandemic originated.
The White House has stated that under the new executive order, all U.S. financial support for gain-of-function studies will be halted in countries considered problematic like China and Iran, along with other international entities deemed lacking adequate research monitoring systems. Additionally, the directive forbids American funds from supporting overseas projects that could potentially trigger future pandemics.
According to a White House fact sheet, the directive also “enables U.S. research organizations to pinpoint and terminate federal financing for additional biological studies that might endanger the well-being, safety, or security of Americans.”
The directive aims “to enhance the safety and security of biological research without hindering U.S. innovation,” according to the White House.
The White House similarly released statements from multiple officials during the Trump administration who contended that the funding limitation is essential.
“President Trump deserves praise for his bravery and foresight,” stated Health and Human Services Secretary Robert F. Kennedy Jr.
“This marks an important moment,” stated Dr. Jay Bhattacharya, who leads the National Institutes of Health. “Carrying out this research isn’t a safeguard against pandemics, contrary to what certain individuals may believe; it won’t shield us from threats posed by other countries either. There’s always a risk that during such studies, accidents could occur leading to unintentional outbreaks.”
“It’s astounding to consider that this whole ordeal might have been triggered by scientists tampering with natural processes in a lab using advanced technology,” stated Dr. Marty Makary, who serves as the Commissioner of the Food and Drug Administration.
Copyright 2025 NPR